Send me a link:
*Only U.S. numbers are accepted. Text messaging rates may apply.
Please enter a valid phone number.
Please enter your Phone Number.
Thanks! A link has been sent.
Vivus (VVUS) shares rose 13.3% to 11.73 Wed. after insurer Aetna (AET) on Tue. revised its weight-loss-treatment policy to include Vivus' obesity drug Qsymia.